Quintiles inks deal to promote COPD drug in U.K.

Spanish drugmaker Almirall has extended its relationship with Quintiles, tabbing the CRO to promote its respiratory portfolio and new COPD drug in the U.K. The drug got its European approval last week, and the partnership follows Quintiles' work in clinical trials for the treatment. Neither company disclosed the terms of the deal. Release

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.